ASTM F 2103 : 2011-03

Superseded

Superseded A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View superseded by

GUIDE FOR CHARACTERIZATION AND TESTING OF CHITOSAN SALTS AS STARTING MATERIALS INTENDED FOR USE IN BIOMEDICAL AND TISSUE-ENGINEERED MEDICAL PRODUCT APPLICATIONS

Available format(s):

Superseded date: 04-10-2015

Language(s):

Published date: 01-03-2011

Publisher: American Society for Testing and Materials

Abstract - (Show below) - (Hide below)

CONTAINED IN VOL. 13.01, 2015 Describes the evaluation of chitosan salts suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, tissue-engineered medical products (TEMPS).

General Product Information - (Show below) - (Hide below)

Committee	F 04
Document Type	Redline
ISBN
Pages
Published
Publisher	American Society for Testing and Materials
Status	Superseded
Superseded By	ASTM F 2103 : 2018 : REDLINE

Standards Referenced By This Book - (Show below) - (Hide below)

ASTM F 2260 : 2003 : R2008	Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (¹H NMR) Spectroscopy
ASTM F 2900 : 2011	Standard Guide for Characterization of Hydrogels used in Regenerative Medicine (Withdrawn 2020)
ASTM F 2211 : 2013	Standard Classification for Tissue Engineered Medical Products (TEMPs)
ASTM F 2260 : 2003 : R2012 : EDT 1	Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (¹H NMR) Spectroscopy
ASTM F 2027 : 2016 : REDLINE	Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products
ASTM F 2260 : 2003	Standard Test Method for Determining Degree of Deacetylation in Chitosan Salts by Proton Nuclear Magnetic Resonance (¹H NMR) Spectroscopy

Standards Referencing This Book - (Show below) - (Hide below)

EN 12442-3 : 2000	ANIMAL TISSUES AND THEIR DERIVATIVES UTILIZED IN THE MANUFACTURE OF MEDICAL DEVICES - PART 3: VALIDATION OF THE ELIMINATION AND/OR INACTIVATION OF VIRUSES AND TRANSMISSIBLE AGENTS
AAMI TIR19 : 1998	GUIDANCE FOR ANSI/AAMI/ISO 10993-7: 1995, BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 7: ETHYLENE OXIDE STERILIZATION RESIDUALS
ISO 10993-3:2014	Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
ASTM F 756 : 2017 : REDLINE	Standard Practice for Assessment of Hemolytic Properties of Materials
ASTM F 749 : 2013 : REDLINE	Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit
ASTM F 1903 : 2010-07	PRACTICE FOR TESTING FOR BIOLOGICAL RESPONSES TO PARTICLES IN VITRO
ISO 13408-1:2008	Aseptic processing of health care products — Part 1: General requirements
ASTM F 619 : 2014 : REDLINE	Standard Practice for Extraction of Medical Plastics
ISO 10993-17:2002	Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substances
ISO 10993-1:2009	Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
ASTM F 1904 : 2014 : REDLINE	Standard Practice for Testing the Biological Responses to Particles in vivo
ISO 10993-9:2009	Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products
EN 12442-1 : 2000	ANIMAL TISSUES AND THEIR DERIVATIVES UTILIZED IN THE MANUFACTURE OF MEDICAL DEVICES - PART 1: ANALYSIS AND MANAGEMENT OF RISK

Categories associated with this Standard - (Show below) - (Hide below)

Sub-Categories associated with this Standard - (Show below) - (Hide below)

Sorry this product is not available in your region.

Add To Cart